SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-034961
Filing Date
2024-03-22
Accepted
2024-03-21 20:00:03
Documents
13
Period of Report
2024-03-21
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K prok-20240321.htm   iXBRL 8-K 39011
2 EX-99.1 prok-ex99_1.htm EX-99.1 316894
3 GRAPHIC img22993735_0.jpg GRAPHIC 13089
  Complete submission text file 0000950170-24-034961.txt   509561

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT prok-20240321.xsd EX-101.SCH 25827
16 EXTRACTED XBRL INSTANCE DOCUMENT prok-20240321_htm.xml XML 4900
Mailing Address 2000 FRONTIS PLAZA BLVD. SUITE 250 WINSTON-SALEM NC 27103
Business Address 2000 FRONTIS PLAZA BLVD. SUITE 250 WINSTON-SALEM NC 27103 336-999-7028
PROKIDNEY CORP. (Filer) CIK: 0001850270 (see all company filings)

IRS No.: 981586514 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40560 | Film No.: 24772783
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)